Interpace Diagnostics Group Inc (IDXG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Interpace Diagnostics Group Inc (IDXG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7378
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform. It also provides ThyGenX and ThyraMIR that collectively assess the risk of benign or malignant thyroid nodules, and minimizes unnecessary surgeries. Interpace Diagnostics offers diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers. The company operates through its labs located in Pennsylvania, Pittsburgh, and New Haven, the US. Interpace Diagnostics is headquartered in Parsippany, New Jersey, the US.

Interpace Diagnostics Group Inc (IDXG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interpace Diagnostics Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Interpace Diagnostics Group Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 10
Venture Financing 12
Interpace Diagnostics Raises USD5 Million in Venture Financing 12
Interpace Diagnostics Raises USD0.1 Million in Venture Financing 13
Partnerships 14
Interpace Diagnostics Enters into Research Agreement with Viatar CTC Solutions 14
Interpace Diagnostics Enters into Partnership Agreement with Prolias Technologies 15
Equity Offering 16
Interpace Diagnostics Plans to Raise up to USD50 Million in Public Offering of Securities 16
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 17
Interpace Diagnostics Raises USD4.3 Million in Private Placement of Shares 18
Interpace Diagnostics Raises USD2 Million in Private Placement of Shares and Warrants 19
Acquisition 20
PDI Acquires RedPath Integrated Pathology for USD23 Million 20
PDI Receives Option To Acquire Molecular Diagnostics Company 22
Interpace Diagnostics Group Inc – Key Competitors 23
Interpace Diagnostics Group Inc – Key Employees 24
Interpace Diagnostics Group Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Mar 15, 2018: Interpace Diagnostics Group Announces Fourth Quarter and Full Year 2017 Financial Results 26
Legal and Regulatory 28
Jan 17, 2017: Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement 28
Other Significant Developments 29
Dec 18, 2017: Interpace Diagnostics Announces Agreement with ARUP Laboratories 29
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Interpace Diagnostics Group Inc, Medical Equipment, Key Facts, 2017 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interpace Diagnostics Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interpace Diagnostics Group Inc, Deals By Market, 2012 to YTD 2018 8
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 10
Interpace Diagnostics Raises USD5 Million in Venture Financing 12
Interpace Diagnostics Raises USD0.1 Million in Venture Financing 13
Interpace Diagnostics Enters into Research Agreement with Viatar CTC Solutions 14
Interpace Diagnostics Enters into Partnership Agreement with Prolias Technologies 15
Interpace Diagnostics Plans to Raise up to USD50 Million in Public Offering of Securities 16
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 17
Interpace Diagnostics Raises USD4.3 Million in Private Placement of Shares 18
Interpace Diagnostics Raises USD2 Million in Private Placement of Shares and Warrants 19
PDI Acquires RedPath Integrated Pathology for USD23 Million 20
PDI Receives Option To Acquire Molecular Diagnostics Company 22
Interpace Diagnostics Group Inc, Key Competitors 23
Interpace Diagnostics Group Inc, Key Employees 24
Interpace Diagnostics Group Inc, Subsidiaries 25

List of Figures
Interpace Diagnostics Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interpace Diagnostics Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interpace Diagnostics Group Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Interpace Diagnostics Group Inc (IDXG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MannKind Corp (MNKD):企業の財務・戦略的SWOT分析
    MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Landesbank Berlin Holding Ag
    Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Fastenal Co:戦略・SWOT・企業財務分析
    Fastenal Co - Strategy, SWOT and Corporate Finance Report Summary Fastenal Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Aushon BioSystems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that offers biomarker measurement and analysis products. The company provides biomarker therapeutic areas in microarray printing technology. Its products include ciraplex assay, cirascan imaging and cirasoft analysis and cira servic …
  • Tenaga Nasional Berhad (TENAGA)-エネルギー分野:企業M&A・提携分析
    Summary Tenaga Nasional Berhad (TNB) is an electricity utility that generates, transmits, distributes and supplies power. It develops, operates and maintains a portfolio of power generating units. The company produces electricity from crude oil, natural gas, hydro, coal and gas sources. TNB also sup …
  • Mattel, Inc.:企業の戦略・SWOT・財務情報
    Mattel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mattel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TOKIN Corp:企業の戦略的SWOT分析
    TOKIN Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Empresas Publicas De Medellin ESP:企業の戦略的SWOT分析
    Empresas Publicas De Medellin ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • EVN AG (EVN)-エネルギー分野:企業M&A・提携分析
    Summary EVN AG (EVN) is an energy and environmental services company. It provides electricity, natural gas, heat, drinking water, wastewater treatment, thermal waste utilization, and related services. The company produces power from thermal and renewable sources. EVN procures electricity, natural ga …
  • Linde AG (LIN)-石油・ガス分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tetraphase Pharmaceuticals Inc (TTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases cau …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd, is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, manages, produces and develops oil and gas properties in Western Canada …
  • Ashok Leyland Limited:企業のM&A・事業提携・投資動向
    Ashok Leyland Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ashok Leyland Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Aspen Pharmacare Holdings Ltd (APN)-製薬・医療分野:企業M&A・提携分析
    Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturi …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • Curtiss-Wright Corporation (CW)-エネルギー分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • Bank of Montreal:企業のM&A・事業提携・投資動向
    Bank of Montreal - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Montreal Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • LT Group, Inc. (LTG):企業の財務・戦略的SWOT分析
    LT Group, Inc. (LTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆